Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

17.30
Delayed Data
As of Jul 06
 +0.55 / +3.28%
Today’s Change
7.31
Today|||52-Week Range
18.55
+108.43%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close16.75
Today’s open16.59
Day’s range16.41 - 17.36
Volume666,019
Average volume (3 months)1,055,690
Market cap$800.0M
Dividend yield--
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-51.56%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio24.5
Price/Sales3.44
Price/Book10.09

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...+0.54+2.15%
ENTAEnanta Pharmaceutica...+1.62+3.75%
COCPCocrystal Pharma Inc+0.01+0.88%
AMPHAmphastar Pharmaceut...+0.10+0.58%
Data as of 3:54pm ET, 07/06/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers